Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.94 USD | -18.66% | -19.33% | +35.24% |
05:37pm | Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-09 | Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.24% | 3.76B | |
-28.63% | 9.96B | |
-21.01% | 2.37B | |
-11.15% | 2.27B | |
-22.94% | 1.58B | |
+59.69% | 1.31B | |
-1.31% | 750M | |
+20.42% | 575M | |
-27.55% | 525M | |
+5.37% | 337M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics Insider Bought Shares Worth $2,287,500, According to a Recent SEC Filing